A comprehensive view of Phase 2 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

Regeneron lists Phase 1/2 clinical trial to study REGN10597 in patients with advanced solid organ malignancies; trial aims to evaluate safety, tolerability, and activity of the anti-PD-1-IL2RA-IL2 fusion protein

Biopharma firm BioVersys extends partnership with GSK to expedite the development of alpibectir for treating tuberculosis; Alpibectir is presently in Phase 2a trial stage

'Antagonistic CD40 Monoclonal Antibodies and Uses Thereof' in Patent Application Approval Process (USPTO 20240124597)

Researchers Submit Patent Application, 'Antibody Which Binds To Myelin Oligodendrocyte Glycoprotein', for Approval (USPTO 20240124577)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count